EurekAlert! -
23 Jul 2020 06:00
(AlphaMed Press) A new platform reported on in STEM CELLS Translational Medicine (SCTM) will enable long-term tracking of cardiomyocytes produced from induced pluripotent stem cells (iPSCs) after implantation into the heart.
Share this Article